John K Ferguson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
John K Ferguson has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Allen C Cheng
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC
2 shared publicationsCaroline L Marshall
Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC
2 shared publicationsRhonda L Stuart
Department of Infectious Diseases, Monash Medical Centre, Melbourne, VIC
2 shared publicationsChristopher Oldmeadow
Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, NSW
1 shared publicationKristi Kozierowski
John Hunter Hospital, Newcastle, NSW
1 shared publicationP. A. Wilson
Infectious Diseases and Immunology Unit, John Hunter Hospital, New South Wales, Australia
1 shared publication
Latest Publications
- 2 June 2019
- Published by Wiley in Medical Journal of Australia
- Vol. 211 (3) , 126-127
Reduced VRE and MRSA colonisation and infection following sustained reduction in broad spectrum antibiotic use in a large tertiary hospital
- 2 June 2019
- Published by Wiley in Medical Journal of Australia
- Vol. 211 (3) , 126-127
Reduced VRE and MRSA colonisation and infection following sustained reduction in broad spectrum antibiotic use in a large tertiary hospital
- 7 December 2009
- Published by AMPCo in Medical Journal of Australia
- Vol. 191 (11-12) , 667
ASID (HICSIG) position statement: infection control guidelines for patients with influenza‐like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities
Click on the article title to read more.
- 7 December 2009
- Published by AMPCo in Medical Journal of Australia
- Vol. 191 (11-12) , 667
ASID (HICSIG) position statement: infection control guidelines for patients with influenza‐like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities
Click on the article title to read more.
- 19 October 2009
- Published by AMPCo in Medical Journal of Australia
- Vol. 191 (8) , 454-458
ASID (HICSIG) position statement: infection control guidelines for patients with influenza‐like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities
Standard and Droplet Precautions are considered adequate to control the transmission of influenza in most health care situations. Vaccination of health care staff, carers and vulnerable patients agai...
- 19 October 2009
- Published by AMPCo in Medical Journal of Australia
- Vol. 191 (8) , 454-458
ASID (HICSIG) position statement: infection control guidelines for patients with influenza‐like illnesses, including pandemic (H1N1) influenza 2009, in Australian health care facilities
Standard and Droplet Precautions are considered adequate to control the transmission of influenza in most health care situations. Vaccination of health care staff, carers and vulnerable patients agai...
- 25 November 2005
- Published by Wiley in Internal Medicine Journal
- Vol. 35 (12) , 699-705
Severe community‐acquired pneumonia: an Australian perspective
Severe community-acquired pneumonia (CAP) is a common disease with a relatively high mortality. The initial treatment is empirical, based on a broad range of potential pathogens. There are minimal published data describing microbiological causes of pneumonia in Australia. To describe the aetiology and characteristics of severe CAP in patients requiring intensive care unit (ICU) admission, to identify factors predicting mortality and to audit current practices of investigation and antibiotic management of these patients from an Australian perspective. A retrospective analysis of patient case notes was performed for 96 consecutive patients admitted to two ICU with severe CAP. Data recorded included patient demographics, comorbidities, antimicrobial treatment, investigations and outcome (mortality, length of stay). Overall, mortality was 32%. A microbiological diagnosis was made in 46% of patients. The most frequent causative organisms were Streptococcus pneumoniae (13 cases), influenza A (9), Haemophilus influenzae (5) and Staphylococcus aureus (4); aerobic Gram-negative bacilli collectively accounted for five cases. Blood cultures were positive in 20% of patients. Seventy patients (73%) required mechanical ventilation and 61 patients (63%) required inotropic support. Laboratory abnormalities including acute renal failure, metabolic acidosis and coagulopathy were frequent. Factors associated with mortality on multivariate analysis were age, antibiotic administration prior to hospital presentation, delay in hospital antibiotic administration of more than 4 h, and presence of multilobar or bilateral consolidation on chest X-ray. Severe CAP requiring ICU admission was associated with a mortality rate of 32%, despite appropriate antimicrobial therapy including a beta-lactam and a macrolide antibiotic in most cases. Causative organisms identified were similar to those found in previous studies. High rates of viral causes (28% of identified pathogens) were noted. Low rates of legionellosis and other atypical causes were found, most probably due to a lack of systematic testing for these agents.
- 25 November 2005
- Published by Wiley in Internal Medicine Journal
- Vol. 35 (12) , 699-705
Severe community‐acquired pneumonia: an Australian perspective
Severe community-acquired pneumonia (CAP) is a common disease with a relatively high mortality. The initial treatment is empirical, based on a broad range of potential pathogens. There are minimal published data describing microbiological causes of pneumonia in Australia. To describe the aetiology and characteristics of severe CAP in patients requiring intensive care unit (ICU) admission, to identify factors predicting mortality and to audit current practices of investigation and antibiotic management of these patients from an Australian perspective. A retrospective analysis of patient case notes was performed for 96 consecutive patients admitted to two ICU with severe CAP. Data recorded included patient demographics, comorbidities, antimicrobial treatment, investigations and outcome (mortality, length of stay). Overall, mortality was 32%. A microbiological diagnosis was made in 46% of patients. The most frequent causative organisms were Streptococcus pneumoniae (13 cases), influenza A (9), Haemophilus influenzae (5) and Staphylococcus aureus (4); aerobic Gram-negative bacilli collectively accounted for five cases. Blood cultures were positive in 20% of patients. Seventy patients (73%) required mechanical ventilation and 61 patients (63%) required inotropic support. Laboratory abnormalities including acute renal failure, metabolic acidosis and coagulopathy were frequent. Factors associated with mortality on multivariate analysis were age, antibiotic administration prior to hospital presentation, delay in hospital antibiotic administration of more than 4 h, and presence of multilobar or bilateral consolidation on chest X-ray. Severe CAP requiring ICU admission was associated with a mortality rate of 32%, despite appropriate antimicrobial therapy including a beta-lactam and a macrolide antibiotic in most cases. Causative organisms identified were similar to those found in previous studies. High rates of viral causes (28% of identified pathogens) were noted. Low rates of legionellosis and other atypical causes were found, most probably due to a lack of systematic testing for these agents.